No insider purchase over the last 90 days. The latest, by 박윤정, was filed 05 Aug 2026.
NIBEC Co., Ltd.: what insiders have been doing
NIBEC Co., Ltd. is a Health Care company. Its directors and officers file their transactions with DART (FSS). In the past year (1 November 2025 to 1 November 2026), 3 filings came from 2 insiders.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase, made by 1 insider. The totals exclude 1 filing filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 senior executive among the declarants.
The last insider purchase was made public on 5 August 2026, 97 days ago.
With 3 filings in twelve months, the company is quieter than the median of 7 filings across the 2,655 companies we follow on the same exchange. Since 2021, the database holds 14 purchases and no sales by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and UCB also feature in our signals. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +47.3%Entry ₩13,650 · Close at T+365 ₩20,100
- +47.3%Entry ₩13,650 · Close at T+365 ₩20,100
- -10.9%Entry ₩18,750 · Close at T+365 ₩16,700
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 2,882 sharesShareKRXDART:20260805000229Canonical exit: 3 Nov 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 4,400 sharesKRXDART:20230720000277Canonical exit: 16 Oct 2023 (T+90)
- 900 shares@ ₩11,932.002.8% of flowShareKRXDART:20230720000141Canonical exit: 18 Oct 2023 (T+90)
- 3,000 shares@ ₩11,938.00100.0% of flowShareKRXDART:20230720000158Canonical exit: 16 Oct 2023 (T+90)
- 500 shares@ ₩12,000.001.6% of flowShareKRXDART:20230714000131Canonical exit: 12 Oct 2023 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 10,412 sharesKRXDART:20221130001556Canonical exit: 28 Feb 2023 (T+90)
- 7,412 shares@ ₩19,429.00100.0% of flowShareKRXDART:20221130001512Canonical exit: 22 Feb 2023 (T+90)
- 3,000 shares@ ₩19,242.0015.6% of flowShareKRXDART:20221130001535Canonical exit: 23 Feb 2023 (T+90)
- 5,530 sharesKRXDART:20221017000289Canonical exit: 15 Jan 2023 (T+90)
- 5,530 shares@ ₩16,939.0025.3% of flowShareKRXDART:20221017000281Canonical exit: 9 Jan 2023 (T+90)
- 17,600 sharesKRXDART:20221004000283Canonical exit: 2 Jan 2023 (T+90)
- 11,600 shares@ ₩17,238.0054.7% of flowShareKRXDART:20221004000288Canonical exit: 26 Dec 2022 (T+90)
- 4,000 shares@ ₩9,490.00100.0% of flowShareKRXDART:20221004000292Canonical exit: 21 Jul 2022 (T+90)
- 2,000 shares@ ₩9,490.00100.0% of flowShareKRXDART:20221004000295Canonical exit: 21 Jul 2022 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
25 of 27 declarations
About NIBEC Co., Ltd.
Naivec is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
